News Center - Luye Life Sciences

News Center

Boan Biotech’s First Investigational ADC, BA1301 for Injection, Approved for Clinical Tri...

2023-01-09 MORE>
Boan Biotech Officially Listed on the Main Board of SEHK Accelerating to Become a Leading ...

2023-01-03 MORE>
Luye Pharma’s Innovative Formulation LY03010 Meets Endpoints in Pivotal U.S. Study

2022-11-22 MORE>
China’s First Denosumab Biosimilar Boyoubei® Approved for Launch by NMPA

2022-11-11 MORE>
Luye Pharma’s Class 1 Innovative Antidepressant Ruoxinlin® Approved for Launch in China

2022-11-03 MORE>
Boan Biotech’s BA2101 Injection Approved for Clinical Trials in China

It’s China’s First Long-acting Anti-IL-4Rα Monoclonal Antibody

2022-10-28 MORE>

Total:117 / Page:20 First Prev 3 4 5 6 7 Next Last

鲁ICP备05023892号-5 LUYE All Rights Reserved Privacy policy Terms of use

TOP